and has been successfully targeted using rifampin, which remains a cornerstone of therapy for M. tuberculosis patients (2, 3) . In addition to the subunits that constitute the RNAP holoenzyme in all bacteria (two ␣ subunits and ␤, ␤=, , and subunits), mycobacteria also require two additional essential proteins, RNAP binding protein A (RbpA) and CarD, to form stable transcription initiation complexes (4) (5) (6) (7) . Unlike Escherichia coli, which has been used to define the events of bacterial transcription initiation, mycobacteria are unable to irreversibly form stable RNAP-promoter open complexes (RP o ) and require both RbpA and CarD to reach RP o stability comparable to that of E. coli (4, 7, 8) , which could explain the essentiality of these proteins (9) (10) (11) . Both CarD and RbpA have also been shown to affect the sensitivity of mycobacteria to rifampin (12, 13) . Therefore, improving our understanding of these transcription factors could provide an avenue to future therapies targeting CarD or RbpA while improving the efficacy of currently approved drugs.
RbpA was discovered in Streptomyces coelicolor as a protein that coimmunoprecipitates with the RNAP and is unique to the Actinobacteria phylum (14) . RbpA consists of a central core domain (CD) flanked by an unstructured 26-amino-acid N-terminal tail (NTT) and a C-terminal -interaction domain (SID) linked to the CD by a 15-amino-acid basic linker (BL) (6, 11, 15, 16) . The RbpA SID forms a stable binary complex with group I ( A in M. tuberculosis) and certain group II ( B in M. tuberculosis) factors (6, (14) (15) (16) . Bacterial two-hybrid experiments in S. coelicolor showed that mutating the R88 residue within the RbpA SID to an alanine significantly weakened the interaction between S. coelicolor RbpA and the housekeeping HrdB (15) , highlighting the importance of this residue in the interaction. Based on structural studies, the BL makes electrostatic contacts with the DNA phosphate backbone of the nontemplate strand upstream of the Ϫ10 promoter element in the RP o conformation, the CD is positioned near the RNAP ␤= zinc binding domain, and the NTT threads into the RNAP active site cleft between the ␤= zinc binding domain and the A 4 domain (6, 16, 17) . In support of a functional role for the BL, fluorescence anisotropy experiments showed that addition of M. tuberculosis RbpA to Mycobacterium bovis RNAP-A holoenzyme in the presence of M. tuberculosis CarD decreased the dissociation constant (K d ) of RNAP binding to a vapB10 promoter template and an R79A mutation in the M. tuberculosis RbpA BL abolished the RbpAmediated increases in RNAP affinity for the vapB10 promoter (16) .
Most characterization of RbpA has been performed in vitro, and there have been only limited studies of how the domains of RbpA contribute to gene regulation in mycobacteria. In a recent study using Mycobacterium smegmatis, an R79A mutation in the RbpA BL and deletion of the NTT and CD resulted in slower growth of the bacteria (6) . Herein, we expand on that work and compare the roles of each RbpA domain, both in vitro and in vivo, to show that only the SID is required for association with the RNAP and the activities of different domains affect the expression of distinct gene sets in the bacteria.
RESULTS
Individual RbpA structural domains are important for mycobacterial growth and viability. To distinguish the roles of the RbpA structural domains in mycobacteria (Fig. 1A) , using a previously described gene-swapping method (13, 18) . The R79A mutation is within the BL and should disrupt DNA binding, the R88A mutation in the SID has been shown to weaken the affinity of RbpA for , the position 1 to 71 RbpA fragment is deleted for the BL and SID, and the position 72 to 111 RbpA fragment is deleted for the NTT and CD (Fig. 1) (11, 15, 16 ).
Using the gene-swapping approach, we found that none of the RbpA mutants could support viability in M. tuberculosis (Fig. 1B) The RbpA SID is necessary and sufficient for association with RNAP. Structural studies indicate that RbpA engages in four different macromolecular interactions in mycobacterial RNAP-promoter initiation complexes, i.e., (i) the RbpA NTT binding to RNAP ␤= and , (ii) the RbpA CD binding to RNAP ␤=, (iii) the RbpA BL binding to DNA, and (iv) the RbpA SID binding to (6, 11, 16) ; however, it is not known which of these interactions are required for the association of RbpA with the RNAP. To address this gap in knowledge, we performed coimmunoprecipitation experiments analyzing the amounts of A , B , and RNAP ␤ subunit that coimmunoprecipitated with the RbpA-FLAG-tagged proteins (Fig. 2) . The levels of A and B coimmunoprecipitated with RbpA Mtb R88A -FLAG were dramatically reduced, compared to those coimmunoprecipitated with RbpA Mtb WT -FLAG ( Fig. 2A , B, and C), as expected based on the importance of R88 for binding (15) . In addition to the decreases in A and B levels, the levels of RNAP ␤ coimmunoprecipitated with RbpA Mtb R88A -FLAG were significantly reduced ( Fig.  2A and D) . In crystallographic studies, the R88 in the RbpA SID is not positioned to bind directly to the core RNAP subunits; therefore, we conclude that the reduced ␤ coimmunoprecipitated with RbpA Mtb R88A -FLAG is due to the reduced RbpA-interaction. This indicates that the interaction between the RbpA SID and the subunit is the primary determinant of the association of RbpA with the RNAP. In contrast, deletion of the NTT and CD (RbpA Mtb 72-111 ) did not decrease the amounts of RNAP ␤, A , or B associated with RbpA. Therefore, despite the observations that the CD was positioned to interact with RNAP ␤= and the NTT was positioned to interact with RNAP ␤= and (6, 17), these interactions are not necessary for association with RNAP. Notably, although the levels of RNAP ␤, A , and B coimmunoprecipitated per molecule of RbpA Mtb 72-111 appear to be increased in Fig. 2 , we found that the differences were due to lower levels of RbpA Mtb 72-111 detection by Western blot analysis (data not shown). RbpA Mtb R79A -FLAG coimmunoprecipitated similar levels of ␤ and A , compared to RbpA Mtb WT -FLAG. Coimmunoprecipitated levels of B trended higher with RbpA Mtb R79A -FLAG but were not statistically significantly different from those observed with RbpA Mtb WT -FLAG (Fig. 2) . Collectively, our data show that the RbpA SID is both necessary and sufficient for interaction with RNAP.
RbpA mutants exhibit distinct kinetic phenotypes on the pathway to RP o formation. RbpA has been proposed to accelerate a forward kinetic step in the formation of RP o , resulting in more stable RP o at equilibrium (6, 7) . A real-time fluorescence assay (7) was used to determine the effects of RbpA mutants on RP o formation by the M. tuberculosis RNAP. Briefly, a Cy3 label was incorporated onto the ϩ2 dT nucleotide, with respect to the ϩ1 transcription start site, of the nontemplate strand of the M. tuberculosis rRNA rrnAP3 promoter (19) . The Cy3 label is positioned within the transcription bubble such that, upon opening of the promoter DNA, a 2-fold fluorescence enhancement is observed (20) ; this allows quantitation of the kinetics of RP o equilibration, by monitoring the change in fluorescence as a function of time, and the stability of RP o , by using the equilibrium fluorescence value (4, 7, 21) . Incubating RbpA Mtb WT at a saturating concentration (2 M) with 35 nM M. tuberculosis RNAP-A holoenzyme and the Cy3-labeled rrnAP3 promoter resulted in a greater amount of RP o at equilibrium than observed with RNAP-A holoenzyme and the rrnAP3 promoter alone (Fig. 3A) , consistent with the known role of RbpA in stabilizing the otherwise unstable mycobacterial RNAP open complex (6, 7). When the same concentrations of 
The RbpA SID is necessary and sufficient for the association of RbpA with the RNAP. (A) Western blot analysis of lysates immunoprecipitated for FLAG-tagged RbpA. Monoclonal antibodies specific for FLAG were used to detect RbpA Mtb -FLAG protein variants (bottom row). RNAP ␤ coimmunoprecipitated by the FLAG-tagged RbpA constructs was detected with a monoclonal antibody specific for RNAP ␤, and both A and B were detected using a monoclonal antibody specific for a shared epitope in E. coli 70 RbpA Mtb R79A and RbpA Mtb R88A were added, no enhancement of the amount of RP o at equilibrium over RNAP-A holoenzyme and the rrnAP3 promoter alone was observed ( Fig. 3A and B) , demonstrating the importance of these residues. For a qualitative description of the kinetics, we calculated t 1/2 values (the time required to reach the midpoint of the final equilibrium fluorescence). Interestingly, these mutants exhibited approximately 3-fold faster kinetics (RbpA Mtb R79A t 1/2 of 14.8 Ϯ 1.1 s and RbpA Mtb R88A t 1/2 of 16.4 Ϯ 1.1 s), compared with the RNAP-A holoenzyme and the rrnAP3 promoter alone (t 1/2 of 43 Ϯ 2 s) (Fig. 3C ). The finding of faster kinetics accompanied by no change in the equilibrium fluorescence value suggests that these mutants retain the ability to stabilize the transition state on the pathway to RP o but have lost the ability to stabilize RP o itself. This behavior is analogous to the classic model for enzyme activity (22) , in which the transformation of substrate to product is accelerated without changes in the final equilibrium between the two states. In this scenario, the mutant RbpA proteins may increase the rate of opening and the rate of closing equally, such that the ratio of rates remains constant. These results suggest that the interactions between RbpA and both the promoter DNA (R79) and factor (R88) are essential for RP o stabilization and that RbpA is still capable of catalyzing promoter opening even in the presence of these mutations. To further investigate the domain requirements for RP o stabilization, we repeated the experiments described above with RbpA Mtb 1-71 (containing the NTT and CD) and RbpA (containing the CD only), and we observed minimal enhancement in RP o stability (Fig. 3A and B) and an identical rate of RP o equilibration (t 1/2 of 42 Ϯ 3 s), relative to the RNAP-A holoenzyme and the rrnAP3 promoter alone (Fig. 3A and C) , indicating that the NTT and CD are unable to affect RP o stability on their own. Conversely, RbpA Mtb 72-111 showed the greatest amount of RP o at equilibrium, even higher than that of RbpA Mtb WT (Fig. 3A and B) , with kinetics (t 1/2 of 7.8 Ϯ 0.9 s) similar to those of RbpA Mtb WT (t 1/2 of 6.9 Ϯ 0.5 s) (Fig. 3C) 3A and C) . One possibility consistent with this observation is that, in the presence of the rest of the domains, the NTT decreases the amount of RP o at equilibrium by increasing a reverse rate leading toward the RNAP-promoter closed complex (RP c ). Importantly, performing these experiments with multiple RNAP concentrations suggests that the effect of each RbpA construct is limited by DNA-bound kinetic intermediates and not the rates of association and dissociation of RNAP to and from promoter DNA (see Fig. S1 in the supplemental material). Taken together, these results suggest that residues R79 and R88 are essential for RP o stabilization and that the NTT and CD can inhibit RP o formation. (Table S1 ). The only previous analysis of this type focused on the gene expression profiles that resulted from deletion of the RbpA NTT and CD in M. smegmatis, but it did not investigate the roles of the other RbpA domains (6) . Principal-component analysis (PCA) of the RNA-seq data was performed and provided a general overview of how gene expression patterns among the RbpA mutants clustered in relationship to each other. Three distinct sample clusters were apparent from the PCA results (Fig. 4A) (Fig. 4C and D) . Therefore, the number of shared downregulated or upregulated genes between RbpA Mtb 72-111 and either RbpA Mtb R79A or RbpA Mtb R88A was underenriched ( Table 1 ). Given that RbpA stabilizes RNAP-A -rrnAP3 RP o in vitro and the R79 and R88 residues are essential for this activity, it might be expected that the RbpA BL and SID cooperate to activate transcription from all promoters that RbpA regulates. Similarly, the ability of the NTT and CD to antagonize RbpA-mediated RP o stabilization would lead to the hypothesis that expression from RbpA-regulated genes would be increased in their absence. However, this was not supported by the RNA-seq data, in which similar numbers of transcripts were upregulated and downregulated in each RbpA mutant (Fig. 4B) . These data could mean that domains within RbpA can promote both activation and repression of gene expression. However, it is also possible that there was general downregulation or upregulation of gene expression in the RbpA mutants that we were unable to detect due to the addition of equal amounts of RNA from each strain into the sequencing reaction. To explore this possibility, we performed spike-in experiments (23) (Fig. 4E) . Therefore, despite the findings that deletion of the NTT and CD had only a mild effect on the growth rate ( Fig. 1C and D) and enhanced RP o stabilization activity in vitro (Fig. 3A and B) , the NTT and CD are required for WT levels of gene expression in M. smegmatis. In contrast, qRT-PCR results for the RbpA Mtb R79A and RbpA Mtb R88A mutants were similar to the RNA-seq results, indicating that RbpA Mtb R79A and RbpA Mtb R88A mutants do indeed lead to both upregulation and downregulation of gene expression. When we analyzed the genes that were most upregulated or downregulated with the RbpA Mtb R79A and RbpA Mtb R88A mutants, they fell into multiple diverse functional classes (Table S2 ), indicating that RbpA activity likely affects multiple cellular processes.
DISCUSSION
In this study, we investigated the functions of the individual RbpA structural domains to gain insight into the complex in vivo roles of RbpA. To study the roles of the RbpA NTT and CD, we truncated the N-terminal 71 amino acids of RbpA. The role of the RbpA BL was probed using a point mutation at R79, which has been implicated in the interaction between RbpA and DNA (16) . Finally, we investigated the RbpA SID by using a point mutation at R88, which is one of the key residues needed for the interaction between RbpA and (15) but had yet to be studied in mycobacteria in vivo. We found that the function of each RbpA structural domain is required for M. tuberculosis viability and wild-type growth rates in M. smegmatis and disruption of the RbpA BL and SID functions causes a more severe growth defect than loss of the NTT and CD. a Overlap enrichment of differentially upregulated (log 2 fold change of Ͼ1.0; adjusted P value of Ͻ0.05) and differentially downregulated (log 2 fold change of ϽϪ1.0; adjusted P value of Ͻ0.05) genes for each possible comparison between RbpA Mtb R79A , RbpA Mtb R88A , and RbpA Mtb 72-111 was evaluated by calculating a hypergeometric P value for fold overenrichment (positive values in the fold enrichment column) or underenrichment (negative values in the fold enrichment column). Fold enrichment values were calculated by dividing the number of overlapping genes observed for each comparison by the number of overlapping genes expected when the null hypothesis of no enrichment was accepted for the same comparison. P values indicate the probability that the underenrichment or overenrichment in the overlap of differentially expressed genes of the two strains being compared would occur randomly. P values of Ͻ0.05 are statistically significant.
Our data indicate that M. tuberculosis has a more stringent requirement for RbpA activity, similar to what we observed for CarD (5, 13) .
We determined that the RbpA SID interaction with is the only interaction required for the association of RbpA with the RNAP; the RbpA R88A substitution resulted in not only loss of the interactions with A and B but also almost complete loss of association with the core RNAP ␤ subunit. In contrast, deletion of the NTT and CD did not negatively affect the association of RbpA with RNAP, suggesting that the RbpA NTT and CD serve functions distinct from interaction with RNAP. The RbpA R88A substitution also resulted in decreased RbpA protein levels. Previous studies investigating CarD mutants with altered affinities for the RNAP found that CarD protein levels correlated with CarD affinity for the RNAP (21) . Our data showing that RbpA Mtb R88A has a lower affinity for the RNAP and is present in lower abundance in the cell supports a model in which RbpA protein levels are also affected by its ability to interact with the RNAP. CarD was shown to be a target of the Clp protease in M. tuberculosis and, similarly, RbpA levels were Ͼ2-fold higher in a M. tuberculosis strain lacking Clp protease subunits, suggesting that RbpA protein levels may also be regulated by the Clp protease (24) .
Previous studies investigating the effect of RbpA on RP o stability reported that R79 is required for RP o stabilization, whereas both the NTT and CD are dispensable (6, 7) . We have expanded on these findings by determining that the RbpA-interaction is required for enhanced RP o stability and the NTT and CD antagonize this activity (Fig. 3) . Furthermore, our results suggest that the effect of RbpA on the kinetics of RP o equilibration can be differentiated from its effect on equilibrium levels of RP o and that RbpA can affect both forward and reverse rates on the pathway to RP o , at the concentrations tested. The similar effects of RbpA BL and SID mutations on RP o stabilization (Fig. 3) mirror the significant overlap in the expression profiles of RbpA Mtb R79A and RbpA Mtb R88A (Fig. 4) . In contrast, the truncation of NTT and CD, which affects RP o stability differently than mutations in RbpA BL and CD, results in an expression profile significantly different from that of RbpA Mtb R79A and RbpA Mtb R88A . We have found that RbpA Mtb R79A and RbpA Mtb R88A mutants can result in both upregulation and downregulation of transcript levels in M. smegmatis, depending on the gene. Upregulation of gene expression in RbpA mutants could be due to direct effects with RbpA acting as a repressor in some promoter contexts, due to differences in basal initiation kinetics. However, this observation could also be explained by indirect effects with RbpA enhancing the expression of a transcription factor that represses the expression of a set of genes. Future studies that expand analysis of RbpA past the limited promoters that have been explored in vitro will be necessary to address these possibilities.
Our data from spike-in control qRT-PCR experiments suggest that gene expression is globally downregulated in the M. smegmatis RbpA Mtb 72-111 mutant. This suggests that the NTT and CD are required for efficient gene expression, and it complicates interpretations of the RbpA Mtb 72-111 RNA-seq data in this study. This finding may also have an impact on a previously published RNA-seq data set for the M. smegmatis RbpA Mtb 72-111 strain (6). When we compared our RNA-seq data set for RbpA Mtb
72-111
with the previously reported data, we found that there was no significant overlap in genes that registered as upregulated or downregulated. This could be due to a difference in the culturing methods used in the two studies and/or it could be related to the finding that gene expression in general is less robust. How the NTT and CD mechanistically promote efficient gene expression while antagonizing RP o stability on the rrnAP3 promoter in vitro remains an open question for future studies. (ii) Mycobacterium smegmatis. All M. smegmatis strains were derived from mc 2 155 and grown at 37°C in LB medium supplemented with 0.5% dextrose, 0.5% glycerol, and 0.05% Tween 80 (broth). The M. smegmatis merodiploid strain was constructed by integrating pMSG430-rbpA Mtb WT into the attB site of mc 2 155. The M. smegmatis merodiploid strain was transformed with pDB88, with homology to mc 2 155 nucleotides 3928650 to 3929246 and 3929589 to 3930405, to replace the endogenous rbpA, using two-step allelic exchange as described previously (25) Antibiotics and chemicals. In mycobacterial cultures, 20 g/ml kanamycin and 12.5 g/ml zeocin were used. In E. coli cultures, 40 g/ml kanamycin, 50 g/ml chloramphenicol, 50 g/ml streptomycin, and 100 g/ml ampicillin were used.
MATERIALS AND METHODS
Western blotting and immunoprecipitation. For immunoprecipitation, 1-liter cultures were pelleted by centrifugation, resuspended in 20 ml of 1ϫ phosphate-buffered saline (PBS) with complete protease inhibitor cocktail (Roche), and lysed with high-pressure (30 lb/in 2 ) cell disruption (CF model; Constant Systems, Daventry, UK). The lysate was treated with DNase I (New England BioLabs), added to anti-FLAG affinity gel (clone M2; Sigma-Aldrich, St. Louis, MO), and rotated overnight at 4°C. The protein-agarose matrix was washed three times with NP-40 buffer (10 mM sodium phosphate [pH 8.0], 150 mM NaCl, 1% Nonidet-40, 1ϫ complete protease inhibitor cocktail). The immunoprecipitated protein complexes were eluted with 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 150 g/ml FLAG peptide (SigmaAldrich), 1ϫ complete protease inhibitor cocktail. Protein samples were mixed with SDS-PAGE loading buffer and run on a 4 to 12% Bis-Tris protein gel (Invitrogen). For the Western blot analysis, A and B were detected using a mouse monoclonal antibody against E. coli 70 (clone 2G10; Neoclone, Madison, WI), RNAP ␤ was detected using a mouse monoclonal antibody against E. coli RNAP ␤ (clone 8RB13; Neoclone), and FLAG-tagged RbpA was detected using an anti-FLAG mouse monoclonal antibody (Sigma-Aldrich). Secondary LiCor IRDye 800CW goat anti-mouse IgG polyclonal antibodies were used to detect the primary antibodies. Secondary antibody near-infrared fluorescence was detected with the LiCore Odyssey version 3.0 imaging system, and band intensity was analyzed with Image Studio Lite version 4.0.
Protein purification for biochemical assays. Plasmids containing the Mycobacterium tuberculosis H37Rv genomic DNA encoding the different M. tuberculosis RNAP holoenzyme subunits were a gift from Jayanta Mukhopadhyay (Bose Institute, Kolkata, India) (26, 27) . Expression was carried out in accordance with the method described by Banerjee et al. (26) , with minor exceptions. Briefly, E. coli BL21(DE3) cells were transformed with plasmids pET-Duet-rpoB-rpoC (encoding the ␤ and ␤= subunits), pAcYc-DuetsigA-rpoA (encoding an N-terminal 10ϫHis-tagged A subunit and ␣ subunit), and pCDF-rpoZ (encoding the subunit) and were grown in LB medium at 37°C to an optical density at 600 nm (OD 600 ) of 0.6 to 0.8. The culture was then treated with 0.25 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) and grown overnight at 16°C. Cells were harvested via centrifugation (4,070 ϫ g for 15 min at 4°C), and the resultant pellets were stored at Ϫ80°C. M. tuberculosis RNAP-A holoenzyme was purified according to methods used previously for the M. bovis RNAP core complex (4). M. tuberculosis RbpA constructs were cloned into
